These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
299 related articles for article (PubMed ID: 33907381)
1. Pharmacological Management of Gastro-Esophageal Reflux Disease: An Update of the State-of-the-Art. Savarino V; Marabotto E; Zentilin P; Demarzo MG; de Bortoli N; Savarino E Drug Des Devel Ther; 2021; 15():1609-1621. PubMed ID: 33907381 [TBL] [Abstract][Full Text] [Related]
2. Pathophysiology, diagnosis, and pharmacological treatment of gastro-esophageal reflux disease. Savarino V; Marabotto E; Zentilin P; Furnari M; Bodini G; De Maria C; Tolone S; De Bortoli N; Frazzoni M; Savarino E Expert Rev Clin Pharmacol; 2020 Apr; 13(4):437-449. PubMed ID: 32253948 [TBL] [Abstract][Full Text] [Related]
3. Evaluation of proton pump inhibitor-resistant nonerosive reflux disease by esophageal manometry and 24-hour esophageal impedance and pH monitoring. Kawamura O; Hosaka H; Shimoyama Y; Kawada A; Kuribayashi S; Kusano M; Yamada M Digestion; 2015; 91(1):19-25. PubMed ID: 25632912 [TBL] [Abstract][Full Text] [Related]
4. Proton pump inhibitor resistance, the real challenge in gastro-esophageal reflux disease. Cicala M; Emerenziani S; Guarino MP; Ribolsi M World J Gastroenterol; 2013 Oct; 19(39):6529-35. PubMed ID: 24151377 [TBL] [Abstract][Full Text] [Related]
5. Predictors of proton pump inhibitor failure in non-erosive reflux disease: A study with impedance-pH monitoring and high-resolution manometry. Shi Y; Tan N; Zhang N; Xiong L; Peng S; Lin J; Chen M; Xiao Y Neurogastroenterol Motil; 2016 May; 28(5):674-9. PubMed ID: 26768192 [TBL] [Abstract][Full Text] [Related]
6. Multimodality evaluation of patients with gastroesophageal reflux disease symptoms who have failed empiric proton pump inhibitor therapy. Galindo G; Vassalle J; Marcus SN; Triadafilopoulos G Dis Esophagus; 2013 Jul; 26(5):443-50. PubMed ID: 22862422 [TBL] [Abstract][Full Text] [Related]
7. How many cases of laryngopharyngeal reflux suspected by laryngoscopy are gastroesophageal reflux disease-related? de Bortoli N; Nacci A; Savarino E; Martinucci I; Bellini M; Fattori B; Ceccarelli L; Costa F; Mumolo MG; Ricchiuti A; Savarino V; Berrettini S; Marchi S World J Gastroenterol; 2012 Aug; 18(32):4363-70. PubMed ID: 22969200 [TBL] [Abstract][Full Text] [Related]
8. Proton pump inhibitor responders who are not confirmed as GERD patients with impedance and pH monitoring: who are they? de Bortoli N; Martinucci I; Savarino E; Bellini M; Bredenoord AJ; Franchi R; Bertani L; Furnari M; Savarino V; Blandizzi C; Marchi S Neurogastroenterol Motil; 2014 Jan; 26(1):28-35. PubMed ID: 23992024 [TBL] [Abstract][Full Text] [Related]
10. ARE THE PERSISTENT SYMPTOMS TO PROTON PUMP INHIBITOR THERAPY DUE TO REFRACTORY GASTROESOPHAGEAL REFLUX DISEASE OR TO OTHER DISORDERS? Azzam RS Arq Gastroenterol; 2018 Nov; 55Suppl 1(Suppl 1):85-91. PubMed ID: 30304291 [TBL] [Abstract][Full Text] [Related]
11. Role of esophageal manometry and 24-h pH testing in patients with refractory reflux symptoms. Jain M; Agrawal V Indian J Gastroenterol; 2020 Apr; 39(2):165-170. PubMed ID: 32388711 [TBL] [Abstract][Full Text] [Related]
12. AGA Clinical Practice Update on the Personalized Approach to the Evaluation and Management of GERD: Expert Review. Yadlapati R; Gyawali CP; Pandolfino JE; Clin Gastroenterol Hepatol; 2022 May; 20(5):984-994.e1. PubMed ID: 35123084 [TBL] [Abstract][Full Text] [Related]
13. Algorithmic approach to patients presenting with heartburn and epigastric pain refractory to empiric proton pump inhibitor therapy. Roorda AK; Marcus SN; Triadafilopoulos G Dig Dis Sci; 2011 Oct; 56(10):2871-8. PubMed ID: 21512760 [TBL] [Abstract][Full Text] [Related]
14. Combined esophageal multichannel intraluminal impedance and pH monitoring (MII -pH) in the diagnostics and treatment of gastroesophageal reflux disease and its complications. Masiak W; Wallner G; Wallner J; Pedowski T; Solecki M Pol Przegl Chir; 2011 Sep; 83(9):488-96. PubMed ID: 22166737 [TBL] [Abstract][Full Text] [Related]
15. Adding Acotiamide to Gastric Acid Inhibitors Is Effective for Treating Refractory Symptoms in Patients with Non-erosive Reflux Disease. Yamashita H; Okada A; Naora K; Hongoh M; Kinoshita Y Dig Dis Sci; 2019 Mar; 64(3):823-831. PubMed ID: 30465175 [TBL] [Abstract][Full Text] [Related]